**PURPOSE:** The treatment of keloid scars in not clearly established and causes many patients to suffer. Many studies have been conducted to differentiate keloids from normal skin. Previous studies have not directly addressed the effects of epidermal growth factor (EGF) and transforming growth factor (TGF)-β1 on keloid fibroblasts in an intracellular environment. In this study, we have investigated the effects of EGF and TGF-β1 on keloid fibroblasts in an intracellular environment.

**MATERIALS AND METHODS:** The keloid tissues were collected from patients after surgical resection. Active and inactive keloids were differentiated based on clinical symptoms and keloid patterns. A total of 17 patients were enrolled, and 4 normal tissues, 8 inactive keloid tissues, and 5 active keloid tissues were obtained. From each tissue sample, fibroblasts were cultured without any stimulation and the expression of different biomarkers was estimated. The fibroblasts were then stimulated with 10 ng/ml of EGF and TGF-β1, and changes in the expression of the biomarkers were estimated using quantitative polymerase chain reaction.

**RESULTS:** FSP-1, TGF-β1, α-SMA, and COL1A1 expression levels showed a difference of \>2-fold and were highly expressed in active keloids. TGF-β1 expression was decreased in the active keloids after stimulation with EGF, and the TGF-β1 expression was increased in the inactive keloids. When stimulated with TGF-β1, the expression of α-SMA, COL1A1, and TGF-β1 was significantly increased in the active keloids, whereas the expression of TGF-β3 was decreased.

**DISCUSSION:** The decreased expression of TGF-β1 and increased expression of TGF-β3 after TGF-β1 stimulation indicated a decrease in fibrotic factors and an increase in antifibrotic factors. Excessive stimulation of TGF-β1 is thought to stimulate the antifibrotic pathway. The addition of EGF led to the reduced expression of TGF-β1 and stimulation of the antifibrotic pathway.

**CONCLUSION:** Overall, our results show that EGF and TGF-β1 can influence the genetic markers in keloid tissue and stimulate the antifibrotic pathway within the intracellular environment.
